IL-4/CCL22/CCR4 axis controls regulatory T-cell migration that suppresses inflammatory bone loss in murine experimental periodontitis

Journal of Bone and Mineral Research

Volumn 30, Issue 3, 2015, Pages 400-410

  Araujo Pires, Ana Claudia ^a   Vieira, Andreia Espindola ^a   Francisconi, Carolina Favaro ^a   Biguetti, Claudia Cristina ^a   Glowacki, Andrew ^b,c   Yoshizawa, Sayuri ^c   Campanelli, Ana Paula ^a   Trombone, Ana Paula Favaro ^d   Sfeir, Charles S ^b,c   Little, Steven R ^b,c,e   Garlet, Gustavo Pompermaier ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b University of Pittsburgh   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSIDADE DO SAGRADO CORAÇÃO   (Brazil)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Bone resorption; Chemokines; Cytokines; Osteoimmunology; Periodontal disease

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR8; INTERLEUKIN 4; MACROPHAGE DERIVED CHEMOKINE; POLYGLACTIN; CCL22 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; MALE; MOUSE; NONHUMAN; OSTEOLYSIS; PERIODONTITIS; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TH2 CELL; ANIMAL; C57BL MOUSE; METABOLISM; OSTEITIS; OSTEOPOROSIS; PATHOLOGY;

ANIMALS; CHEMOKINE CCL22; INTERLEUKIN-4; MALE; MICE; MICE, INBRED C57BL; OSTEITIS; OSTEOPOROSIS; PERIODONTITIS; T-LYMPHOCYTES, REGULATORY;

EID: 84922848675     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2376     Document Type: Article

References (45)

1. Tonetti MS, Claffey N. European Workshop in Periodontology Group C. Advances in the progression of periodontitis and proposal of definitions of a periodontitis case and disease progression for use in risk factor research. Group C consensus report of the 5th European Workshop in Periodontology. J Clin Periodontol. 2005;32 (Suppl 6): 210-3.
2. Albiger B, Dahlberg S, Henriques-Normark B, Normark S. Role of the innate immune system in host defence against bacterial infections: Focus on the Toll-like receptors. J Intern Med. 2007;261(6): 511-28.
3. Kornman KS, Crane A, Wang HY, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol. 1997;24(1): 72-7.
4. Garlet GP. Destructive and protective roles of cytokines in periodontitis: A re-appraisal from host defense and tissue destruction viewpoints. J Dent Res. 2010;89(12): 1349-63.
5. Glowacki AJ, Yoshizawa S, Jhunjhunwala S, et al. Prevention of inflammation-mediated bone loss in murine, canine periodontal disease via recruitment of regulatory lymphocytes. Proc Natl Acad Sci U S.A. 2013;110(46): 18525-30.
6. Kochetkova I, Thornburg T, Callis G, Pascual DW. Segregated regulatory CD39 + CD4+ T cell function: TGF-beta-producing Foxp3-and IL-10-producing Foxp3+ cells are interdependent for protection against collagen-induced arthritis. J Immunol. 2011;187 (9): 4654-66.
7. Lubberts E, Joosten LA, Chabaud M, et al. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J Clin Invest. 2000;105(12): 1697-710.
8. Garlet GP, Cardoso CR, Mariano FS, et al. Regulatory T cells attenuate experimental periodontitis progression in mice. J Clin Periodontol. 2010;37(7): 591-600.
9. Garlet GP, Cardoso CR, Silva TA, et al. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol. 2006;21(1): 12-20.
10. Garlet GP, Avila-Campos MJ, Milanezi CM, Ferreira BR, Silva JS. Actinobacillus actinomycetemcomitans-induced periodontal disease in mice: Patterns of cytokine, chemokine, and chemokine receptor expression and leukocyte migration. Microbes Infect. 2005;7(4): 738-47.
11. Araujo-Pires AC, Francisconi CF, Biguetti CC, et al. Simultaneous analysis of T helper subsets (Th1, Th2, Th9, Th17, Th22, Tfh, Tr1 and Tregs) markers expression in periapical lesions reveals multiple cytokine clusters accountable for lesions activity and inactivity status. J Appl Oral Sci. 2014;22(4): 336-46.
12. Brownlie RJ, Myers LK, Wooley PH, et al. Treatment of murine collagen-induced arthritis by the stress protein BiP via interleukin-4-producing regulatory T cells: A novel function for an ancient protein. Arthritis Rheum. 2006;54(3): 854-63.
13. Griffith JW, Sokol CL, Luster AD. Chemokines and chemokine receptors: Positioning cells for host defense and immunity. Annu Rev Immunol. 2014;32: 659-702.
14. Repeke CE, Ferreira SB Jr, Claudino M, et al. Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice. Bone. 2010;46(4): 1122-30.
15. Garlet GP, Cardoso CR, Campanelli AP, et al. The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: Host protection and tissue destruction. Clin Exp Immunol. 2007;147(1): 128-38.
16. Cao Y, Xu W, Xiong S. Adoptive transfer of regulatory T cells protects against Coxsackievirus B3-induced cardiac fibrosis. PLoS One. 2013;8 (9): E74955.
17. Xu L, Xu W, Wen Z, Xiong S. In situ prior proliferation of CD4+ CCR6+ regulatory T cells facilitated by TGF-beta secreting DCs is crucial for their enrichment and suppression in tumor immunity. PLoS One. 2011;6(5): E20282.
18. Iellem A, Mariani M, Lang R, et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med. 2001;194 (6): 847-53.
19. Jakubzick C, Wen H, Matsukawa A, Keller M, Kunkel SL, Hogaboam CM. Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice. AmJ Pathol. 2004;165(4): 1211-21.
20. Repeke CE, Ferreira SB Jr, Vieira AE, et al. Dose-response met-RANTES treatment of experimental periodontitis: A narrow edge between the disease severity attenuation and infection control. PLoS One. 2011;6 (7): E22526.
21. Jhunjhunwala S, Raimondi G, Glowacki AJ, et al. Bioinspired controlled release of CCL22 recruits regulatory T cells in vivo. Adv Mater. 2012;24(35): 4735-8.
22. Trombone AP, Ferreira SB Jr, Raimundo FM, et al. Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: Increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection. J Periodontal Res. 2009;44(4): 443-51.
23. Ferreira SBJr, Repeke CE, Raimundo FM, et al. CCR5 mediates proosteoclastic and osteoclastogenic leukocyte chemoattraction. J Dent Res. 2011;90(5): 632-7.
24. Hori S. Lineage stability and phenotypic plasticity of Foxp3(+) regulatory T cells. Immunol Rev. 2014;259(1): 159-72.
25. Burzyn D, Benoist C, Mathis D. Regulatory T cells in nonlymphoid tissues. Nat Immunol. 2013;14(10): 1007-13.
26. Komiya T, Sugiyama T, Takeda K, et al. Suppressive effects of a novel CC chemokine receptor 4 antagonist on Th2 cell trafficking in ligandand antigen-induced mouse models. Eur J Pharmacol. 2013;720(1-3): 335-43.
27. Faustino L, da Fonseca DM, Takenaka MC, et al. Regulatory T cells migrate to airways via CCR4 and attenuate the severity of airway allergic inflammation. J Immunol. 2013;190(6): 2614-21.
28. Afshar R, Strassner JP, Seung E, et al. Compartmentalized chemokinedependent regulatory T-cell inhibition of allergic pulmonary inflammation. J Allergy Clin Immunol. 2013;131(6): 1644-52.
29. Morgan ME, Flierman R, van Duivenvoorde LM, et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum. 2005;52(7): 2212-21.
30. Cardoso CR, Garlet GP, Moreira AP, Junior WM, Rossi MA, Silva JS. Characterization of CD4 + CD25+ natural regulatory T cells in the inflammatory infiltrate of human chronic periodontitis. J Leukoc Biol. 2008;84(1): 311-8.
31. Wu C, Zhou Q, Qin XJ, Qin SM, Shi HZ. CCL22 is involved in the recruitment of CD4 + CD25 high T cells into tuberculous pleural effusions. Respirology. 2010;15(3): 522-9.
32. Andrew DP, Chang MS, McNinch J, et al. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J Immunol. 1998;161(9): 5027-38.
33. Butti E, Bergami A, Recchia A, et al. IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis. Gene Ther. 2008;15(7): 504-15.
34. Myers LK, Tang B, Stuart JM, Kang AH. The role of IL-4 in regulation of murine collagen-induced arthritis. Clin Immunol. 2002;102(2): 185-91.
35. Faustino L, Mucida D, Keller AC, et al. Regulatory T cells accumulate in the lung allergic inflammation and efficiently suppress T-cell proliferation but not Th2 cytokine production. Clin Dev Immunol. 2012;2012: 721817.
36. Kim SH, Evans CH, Kim S, Oligino T, Ghivizzani SC, Robbins PD. Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4. Arthritis Res. 2000;2(4): 293-302.
37. Han WG, van der Voort EI, el Bannoudi H, Louis-Plence P, Huizinga TW, Toes RE. DX5(+)CD4(+) T cells modulate cytokine production by CD4 (+) T cells towards IL-10 via the production of IL-4. Eur J Immunol. 2010;40(10): 2731-40.
38. Charbonnier LM, Han WG, Quentin J, et al. Adoptive transfer of IL-10-secreting CD4 + CD49b+ regulatory T cells suppresses ongoing arthritis. J Autoimmun. 2010;34(4): 390-9.
39. Stein NC, Kreutzmann C, Zimmermann SP, et al. Interleukin-4 and interleukin-13 stimulate the osteoclast inhibitor osteoprotegerin by human endothelial cells through the STAT6 pathway. J Bone Miner Res. 2008;23(5): 750-8.
40. Yamada A, Takami M, Kawawa T, et al. Interleukin-4 inhibition of osteoclast differentiation is stronger than that of interleukin-13 and they are equivalent for induction of osteoprotegerin production from osteoblasts. Immunology. 2007;120(4): 573-9.
41. Mikhak Z, Fukui M, Farsidjani A, Medoff BD, Tager AM, Luster AD. Contribution of CCR4 and CCR8 to antigen-specific T(H)2 cell trafficking in allergic pulmonary inflammation. J Allergy Clin Immunol. 2009;123(1): 67-73. e3.
42. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science. 1997;277 (5334): 2005-7.
43. Cosmi L, Maggi L, Santarlasci V, Liotta F, Annunziato F, T helper cells plasticity in inflammation. Cytometry A. 2014;85(1): 36-42.
44. Hirahara K, Poholek A, Vahedi G, et al. Mechanisms underlying helper T-cell plasticity: Implications for immune-mediated disease. J Allergy Clin Immunol. 2013;131(5): 1276-87.
45. Zhu J, Paul WE. Heterogeneity and plasticity of T helper cells. Cell Res. 2010;20(1): 4-12.